(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RX PHARMACEUTICAL PRECISION PROTECTIONORKIN GOLD MEDAL QA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RX PHARMACEUTICAL PRECISION PROTECTIONORKIN GOLD MEDAL QA

ST13

US500000086344583

Class

37

Filing

86344583

Registration

4788721

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/05/2026

Trademark type

Combined

Nice classes

37

Filing date

07/22/2014

Registration date

08/11/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/10/2026

Last transaction

05/05/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

06/10/2014

First use in commerce

06/10/2014

Drawing code

3

Owner type

03

Owner location

Wilmington, DE, US

Examiner

CARLSEN, EMILY K

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "PHARMACEUTICAL PRECISION PROTECTION" with "PHARMACEUTICAL" inside of a rectangle. To the left is a design including a stylized representation of a container labeled "RX"; to the right is a hexagon design shape containing the wording "ORKIN GOLD MEDAL" and the letters "QA".

Holders and representatives

Holders

Orkin Expansion, Inc.

Representatives

J. Tucker Barr Arnall Golden Gregory LLP

Technical classification

Nice Classes

Class 37

Vienna Codes

No Vienna codes available.

Goods and services

Class 37

Pest control

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/10/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/10/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/10/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/09/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

01/29/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/11/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/02/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/02/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/02/2021

E815

TEAS SECTION 8 & 15 RECEIVED

06/22/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/11/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/25/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/25/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

08/11/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/26/2015

PUBO

PUBLISHED FOR OPPOSITION

05/26/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/06/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/20/2015

ALIE

ASSIGNED TO LIE

04/20/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/30/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/27/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/26/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/26/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/26/2014

GNRT

NON-FINAL ACTION E-MAILED

09/26/2014

CNRT

NON-FINAL ACTION WRITTEN

09/26/2014

DOCK

ASSIGNED TO EXAMINER

09/18/2014

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/31/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2014

NWAP

NEW APPLICATION ENTERED

07/25/2014

Continuous trademark protection

Get notified about every new filing that threatens RX PHARMACEUTICAL PRECISION PROTECTIONORKIN GOLD MEDAL QA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.